Clinical Trials Browser

Phase NA × Carcinoma, Renal Cell × Sorafenib × Clear all

NCT00727532 2019-05-03

Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Phase NA Terminated

9 enrolled 8 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00602862 2013-12-02

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

Phase NA Completed

Carcinoma, Renal Cell